These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20578051)

  • 41. Calciphylaxis: risk factors, diagnosis, and treatment.
    Nigwekar SU; Kroshinsky D; Nazarian RM; Goverman J; Malhotra R; Jackson VA; Kamdar MM; Steele DJ; Thadhani RI
    Am J Kidney Dis; 2015 Jul; 66(1):133-46. PubMed ID: 25960299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate.
    Hackett BC; McAleer MA; Sheehan G; Powell FC; O'Donnell BF
    Clin Exp Dermatol; 2009 Jan; 34(1):39-42. PubMed ID: 18627391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment.
    Chiriac A; Grosu OM; Terinte C; Perţea M
    J Dermatolog Treat; 2020 Aug; 31(5):545-548. PubMed ID: 31075991
    [No Abstract]   [Full Text] [Related]  

  • 44. Multidisciplinary approach to calcific uremic arteriolopathy.
    Nigwekar SU
    Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):531-7. PubMed ID: 26371529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sodium thiosulfate--new hope for the treatment of calciphylaxis].
    Heiro M; Mäkelä L; Koivuviita N; Manner I; Tertti R; Hohenthal U; Metsärinne K
    Duodecim; 2011; 127(16):1690-6. PubMed ID: 21972587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three cases of penile calciphylaxis: diagnosis, treatment strategies, and the role of sodium thiosulfate.
    O'Neil B; Southwick AW
    Urology; 2012 Jul; 80(1):5-8. PubMed ID: 22748863
    [No Abstract]   [Full Text] [Related]  

  • 47. Widespread calciphylaxis and normal renal function: no improvement with sodium thiosulfate.
    Lonowski S; Martin S; Worswick S
    Dermatol Online J; 2015 May; 21(5):. PubMed ID: 26295852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.
    Hanafusa T; Yamaguchi Y; Tani M; Umegaki N; Nishimura Y; Katayama I
    J Am Acad Dermatol; 2007 Dec; 57(6):1021-5. PubMed ID: 18021849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calciphylaxis and sodium thiosulphate: a glimmer of hope in desperate situation.
    Burnie R; Smail S; Javaid MM
    J Ren Care; 2013 Jun; 39(2):71-6. PubMed ID: 23551819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparin.
    Abeck F; Hansen I; Rünger A; Booken N; Schneider SW
    Int J Dermatol; 2024 Jul; 63(7):962-963. PubMed ID: 38504650
    [No Abstract]   [Full Text] [Related]  

  • 51. Calciphylaxis: from the disease to the diseased.
    Oliveira TM; Frazão JM
    J Nephrol; 2015 Oct; 28(5):531-40. PubMed ID: 25835730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calciphylaxis and nephrogenic fibrosing dermopathy with pseudoxanthoma elasticum-like changes: Successful treatment with sodium thiosulfate.
    Ishikawa M; Motegi SI; Toki S; Endo Y; Yasuda M; Ishikawa O
    J Dermatol; 2019 Jul; 46(7):e240-e242. PubMed ID: 30663093
    [No Abstract]   [Full Text] [Related]  

  • 53. Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors.
    Kakagia D; Kriki P; Thodis E; Roumeliotis A; Vargemezis V
    J Cutan Med Surg; 2011; 15(2):121-4. PubMed ID: 21477562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-intervention management of calciphylaxis: a report of 7 cases.
    Baldwin C; Farah M; Leung M; Taylor P; Werb R; Kiaii M; Levin A
    Am J Kidney Dis; 2011 Dec; 58(6):988-91. PubMed ID: 21872378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature.
    Auriemma M; Carbone A; Di Liberato L; Cupaiolo A; Caponio C; De Simone C; Tulli A; Bonomini M; Amerio P
    Am J Clin Dermatol; 2011 Oct; 12(5):339-46. PubMed ID: 21834598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?
    Llach F
    Am J Kidney Dis; 1998 Sep; 32(3):514-8. PubMed ID: 9740172
    [No Abstract]   [Full Text] [Related]  

  • 58. Calciphylaxis: a case report.
    Strippoli D; Simonetti V; Russo G; Motolese A
    Dermatol Ther; 2008; 21 Suppl 3():S26-8. PubMed ID: 19076628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium thiosulphate: a new way of treatment for calciphylaxis?
    Meissner M; Kaufmann R; Gille J
    Dermatology; 2007; 214(4):278-82. PubMed ID: 17460397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain.
    Yang C; Liu Y; Ni H; Li X; Liu H; Zhang X
    J Pak Med Assoc; 2021 Jan; 71(1(B)):367-369. PubMed ID: 35157683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.